Navigation Links
Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger
Date:11/24/2009

BELGRADE, Serbia, Nov. 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, is providing this brief update to its followers and shareholders. HTDS management continues due diligence with the EU stem cell company and merger discussions. This relates to the previous announcement on or about Oct 29, 2009 which the company made. http://www.pinksheets.com/pink/quote/quote.jsp?symbol=HTDS#getNews.

HTDS and Slavica Biochem are also discussing on expanding the research topics to include other applications from the field of regenerative medicine. The newly discussed project would be dealing with a method for treatment of damaged articular cartilage - the autologous implantation of in vitro cultivated chondrocytes (the cells which form the cartilage). This new technique is one of the most important orthopaedic achievements of this century. As aforementioned the research team from Slavica BioChem www.slavicabiochem.com is considering a merger with the bio company from one of the EU countries where this technology is already being deployed. The HTDS management does not wish to disturb its current share structure in the merger discussions. One alternative solution currently being explored by the management is to license this technology and to use HTDS own cash resources and low labour costs in Serbia to launch both enterprises in Serbia. The company would generate revenues with the export throughout western Europe.

Marker Reports and similar research studies indicate that stem cell and regenerative medicine is a ~$25 billion dollar new industry. (2008 data) (source) Jain PharmaBiotech's "Cell Therapy" market report: (1) related to the comme
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment
2. Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery
3. Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
4. Women's Hair Loss Treatment Results Captured on Video to Inspire Others
5. CyberKnife Center of Miami Announces New Cancer Patient Treatment Enhancements
6. Combo Treatment Beneficial in Biliary-Tract Cancer Study
7. Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment
8. NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment
9. Rare pancreatic cancer patients may live longer when treated with radiation therapy
10. IVF Florida Announces New Patient Finance Solution for Fertility Treatments
11. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Healthpointe ... injectable that returns skin to a smooth state, and reduces the appearance of fine ... “first and only FDA-approved injectable gel to instantly add volume to your cheek area ...
(Date:7/28/2015)... ... July 28, 2015 , ... BMI of Texas, which specializes in a ... switch weight loss surgery procedure. Committed to helping patients achieve their weight loss ... of Texas is one of the first practices in South Texas to offer ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... According to ... and Orlando is taking the lead among heroin toxicity cases. According to recent statistic ... overdose. Orlando has become known as a hub of heroin, and law enforcement officials ...
(Date:7/28/2015)... ... 28, 2015 , ... Today, enterprise request management (ERM) and ... upgrade and expansion of its ERM system using Kinetic Data software. ... 134 countries supplying a wide range of business and residential energy products and ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, ... combination products for the treatment of bone disorders and conditions of hair loss, ... entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2
... been identified in at least ten districts of Nairobi. This ... ,Mr Munyao declared that 100,000 doses of vaccines are ... thousand litres of insecticides have also been handed over to ... be dead due to RVF and four hundred cases are ...
... Bangalore: Karnataka is planning to enact legislation to make HIV ... seeking to enter the state legislature. // ,"There is ... in such a legislation within a year," Health Minister R. ... states in the country. ,Ashok said his ministry had ...
... trials in humans to treat obesity from a drug derived ... the Managing Director of the company. ,As per ... and each part of the plant has a different effect ... has the power to curb hunger, some other part of ...
... cases where operations have been cancelled in Great Britain. This has ... ,This was disclosed by Grant Shapps, Conservative MP. According to him ... for this sorry state. This in turn has affected the health ... in a bid to get out of a financial crisis of ...
... no-line bifocal lenses show signs of slower progression of ... to a new// study published in the February 2007 ... ,The study found that among children with ... wearing progressive-addition lenses (PALs) when compared to those wearing ...
... salt-laden foods. The campaign group - Consensus Action on Salt ... excess salt out of food stuff. ,The ... shun salty foods, which will in turn encourage manufacturers to ... avoid buying products which contain either more than 1.25g of ...
Cached Medicine News:Health News:HIV Tests to Be Made Mandatory for Karnataka Couples, Politicians 2
(Date:7/28/2015)... , July 28, 2015  PD-Rx Pharmaceuticals, ... announced that it has partnered with Dobson Technologies, ... as a Service (IaaS) product. PD-Rx ... practices across the United States.  Using Dobson Technologies, ... recovery and business continuity, ensure regulatory compliance, and ...
(Date:7/28/2015)... , July 28, 2015 According ... Market by Type (Dermatology Treatment Devices, and Dermatology Diagnostic ... by Application, by Geography - Analysis and Forecast to ... reach $11.88 billion by 2019, at a CAGR of ... the TOC of Global Dermatology Devices Market for an ...
(Date:7/28/2015)... July 28, 2015   Vincari , known for ... has just hired John O,Neil as their ... has over 30 years of diverse and progressive experience ... executive healthcare experience coupled with Vincari,s CMO, Dr. ... Vincari to address the challenges both hospitals and surgeons ...
Breaking Medicine Technology:PD-Rx Partners With Dobson Technologies 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... at American Society of Clinical Oncology 2009 Annual Meeting ... , , SAN FRANCISCO, June 2 Medivation, ... presentation of new clinical results from a Phase 1-2 ... castration-resistant prostate cancer (CRPC) patients. The new findings, ...
... , Panel Discussant Focuses on Longer Duration of Remission ... Complete Remissions Achieved with Standard Chemotherapy , , ... MTA: CTIC) announced today that at the poster and ... Section at the 2009 American Society of Clinical Oncology ...
Cached Medicine Technology:Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients 2Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients 3Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients 4Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients 5Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 2Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 3Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 4Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 5Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment 6
... ExTOL systems feature your choice of ... electrocardiographs, an easy-to-operate monitor and the ... exercise stress testing systems also feature ... point, pre-programmed or custom protocols, and ...
... Automated Projector Chart w/ Remote/Controller. ... Refraction for Adults & Children. Multiple ... Included. Programmable feature allows you to ... access. Halogen Illumination with Long Life. ...
... The Ultimate in Stability. ... 4.3 stabilizer features superior ... stability in the clamp/turret ... Stabilizer features the ultimate ...
... leader in beating heart bypass, comes the ... NS device is the first leap in ... of surgical revascularization.,The Starfish NS Heart Positioner ... Small Thoracotomy (MVST) procedure without CPB and ...
Medicine Products: